Related Experiment Video
Updated: Nov 9, 2025
09:44
Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen
Published on: November 27, 2019
10.6K
Acute Decompensation and Acute-on-Chronic Liver Failure
Philip Ferstl1, Jonel Trebicka2
1Department for Internal Medicine I, University Hospital, Goethe University, Theodor-Stern-Kai 7, Frankfurt am Main 60590, Germany.
Clinics in Liver Disease
|April 11, 2021
Summary
Liver cirrhosis leads to acute decompensation, often causing organ failure and high mortality. This review covers recent advancements in understanding and managing acute decompensation and acute-on-chronic liver failure.
Area of Science:
- Hepatology
- Internal Medicine
- Critical Care Medicine
Background:
- Liver cirrhosis presents a significant global health challenge.
- Acute decompensation, especially with multi-organ dysfunction, is the primary cause of mortality in cirrhosis patients.
- The progression of decompensation ranges from stable to critical, culminating in acute-on-chronic liver failure (ACLF).
Purpose of the Study:
- To review recent developments in acute decompensation (AD) of liver cirrhosis.
- To focus on the syndrome of acute-on-chronic liver failure (ACLF) and its clinical implications.
Main Methods:
- Literature review of recent studies on AD and ACLF.
- Synthesis of current understanding of disease progression and management strategies.
Main Results:
- AD encompasses a spectrum from stable to critical states.
- ACLF is characterized by high short-term mortality due to systemic inflammation and organ failure.
- Recent research highlights the complex interplay between liver and other organ systems during decompensation.
Conclusions:
- Understanding the trajectory of AD is crucial for timely intervention.
- ACLF represents a distinct, life-threatening complication of cirrhosis requiring focused research and clinical attention.
- Continued investigation into AD and ACLF mechanisms and treatments is essential for improving patient outcomes.
Related Concept Videos
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
67
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
67
01:29Acute Kidney Injury III: Clinical Manifestations
394
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
394
01:22Acute Kidney Injury I: Introduction
245
Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
245
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
50
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
50
01:29Acute Kidney Injury II: Pathophysiology
491
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
491
01:30Acute Pancreatitis II: Clinical Manifestations and Management
396
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
396